· Original article
Kotak portfolio adds five midcaps, sets out rebound triggers
Kotak portfolio changes add five midcaps as the brokerage points to oil relief, stronger earnings and a renewed valuation focus as rebound triggers.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 3,556 · Page 120 / 297
· Original article
Kotak portfolio changes add five midcaps as the brokerage points to oil relief, stronger earnings and a renewed valuation focus as rebound triggers.
· Original article
Exosens revenue growth accelerated in Q3 2026 as European capacity expanded. Nine-month gross margin narrowed, while full-year guidance stayed unchanged.
· Original article
Meta stock offering raises the planned common-share amount to $25 billion, alongside $12.5 billion in mandatory convertible preferred depositary shares.
· Original article
Apple says a small number of iPhone Duo units have screen defects, with AppleCare replacements offered and out-of-warranty repairs priced at $999.
· Original article
Novartis earnings beat third-quarter estimates and the company raised its 2026 core operating income outlook, while free cash flow declined.
· Original article
Pacasmayo earnings rose 69.8% in Q3 2026 as higher sales volumes and cement prices lifted revenue, while its EBITDA margin widened to 34.9%.
· Original article
HSBC earnings show Q3 2026 pretax profit rising 32% to $9.6 billion, alongside a $0.10 interim dividend and a new $1 billion share buyback plan.
· Original article
Brixmor dividend increases 7.3% to $0.33 per share, payable January 15, 2027, as the shopping-center owner reports record leased occupancy.
· Original article
Trip.com introduces My Travel Impact, combining certified hotel stays and estimated transport emissions savings, with coverage dependent on comparable data.
· Original article
Pharming earnings show 21% third-quarter revenue growth and higher profit, with Joenja expansion and November clinical data shaping the outlook.
· Original article
ING buyback repurchased 34.95 million shares, with the bank’s cost capped at €1 billion and its executing broker funding purchases above that limit.
· Original article
OP Pohjola profit fell to EUR 1,396 million in January–September 2026 as investment income weakened, while corporate loans grew about 10%.
Charts and market data by TradingView. Availability and delays vary by exchange.